Valuation: Labcorp Holdings Inc.

Market Cap 2.68TCr 2.39TCr 2.21TCr 2TCr 3.74TCr 2,54000Cr 3.8TCr 27TCr 11TCr 1,33100Cr 10TCr 9.83TCr 4,19600Cr P/E 2026 *
23.7x
P/E 2027 * 21.3x
Enterprise Value 3.19TCr 2.85TCr 2.63TCr 2.39TCr 4.46TCr 3,02900Cr 4.54TCr 32TCr 13TCr 1,58700Cr 12TCr 12TCr 5,00300Cr EV / Sales 2026 *
2.16x
EV / Sales 2027 * 2.02x
Free-Float
99.65%
Yield 2026 *
0.88%
Yield 2027 * 0.89%
1 day+0.24%
1 week+3.97%
Current month+7.29%
1 month+8.75%
3 months+13.59%
6 months+24.78%
Current year+31.77%
1 week 314.68
Extreme 314.685
331.71
1 month 302.71
Extreme 302.71
331.71
Current year 245
Extreme 245
341.8
1 year 244.52
Extreme 244.52
341.8
3 years 191.97
Extreme 191.97
341.8
5 years 191.97
Extreme 191.97
341.8
10 years 98.02
Extreme 98.02
341.8
Date Insider Type Main position Quantity % Market Cap. Importance
01/09/26 Free

Chief Technology Officer

3,000 0.0037%
01/09/26 Free

Chief Technology Officer

750 0.0009%
01/09/26 Free

EVP, COO

900 0.0011%
Change 5-day change 1-year change 3-year change Capi.($)
+0.20%+3.97%+16.40%+67.02% 2.68TCr
-1.12%+1.14%+15.22%+35.40% 12TCr
+0.99%+2.98%+7.35%+96.12% 10TCr
+1.34%+3.11%+108.03%+912.13% 5.96TCr
+2.32%+2.61%-6.79%+78.43% 2.86TCr
+0.09%+3.60%+32.87%+100.46% 2.69TCr
-0.38%+1.08%+30.56%+394.22% 2.18TCr
-2.46%-5.71%-23.11%-7.94% 1.96TCr
-0.34%+3.01%+4.31%+83.40% 1.9TCr
-0.72%-0.89%+80.09% - 1.27TCr
Average -0.01%+0.05%+26.49%+195.47% 4.37TCr
Weighted average by Cap. +0.10%+0.52%+26.23%+200.63%

Financials

2026 *2027 *
Net sales 1.47TCr 1.32TCr 1.22TCr 1.1TCr 2.06TCr 1,40000Cr 2.1TCr 15TCr 5.8TCr 73TCr 5.54TCr 5.42TCr 2,31300Cr 1.55TCr 1.38TCr 1.28TCr 1.16TCr 2.16TCr 1,46800Cr 2.2TCr 15TCr 6.08TCr 77TCr 5.8TCr 5.68TCr 2,42500Cr
Net income 113.05Cr 100.95Cr 93Cr 85Cr 158.12Cr 11TCr 160.73Cr 1.12TCr 444.32Cr 5.62TCr 424.26Cr 415.24Cr 18TCr 124.22Cr 110.93Cr 102.48Cr 93Cr 173.74Cr 12TCr 176.61Cr 1.23TCr 488.22Cr 6.18TCr 466.18Cr 456.27Cr 19TCr
Net Debt 515.05Cr 459.94Cr 424.9Cr 385.05Cr 720.38Cr 49TCr 732.3Cr 5.11TCr 2.02TCr 26TCr 1.93TCr 1.89TCr 81TCr 450.88Cr 402.63Cr 371.95Cr 337.07Cr 630.62Cr 43TCr 641.06Cr 4.48TCr 1.77TCr 22TCr 1.69TCr 1.66TCr 71TCr
Projected Income Statement - Annual - Labcorp Holdings Inc.
Logo Labcorp Holdings Inc.
Labcorp Holdings Inc. provides comprehensive laboratory services that help doctors, hospitals, pharmaceutical companies, researchers and patients. The Company operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The BLS segment provides drug development and CDx development solutions from early-stage research to clinical development, along with support for crop protection and chemical testing, through its ED and Central Laboratory Services businesses. Its service also includes ambulatory outpatient laboratory services. The Company is focused on four primary specialty testing areas, such as oncology, women's health, autoimmune disease, and neurology.
Employees
-
Date Price Change Volume
24/26/24 $330.36 +0.13% 2,89,149
22/26/22 $329.93 +1.91% 9,61,977
21/26/21 $323.75 +0.19% 5,66,728
20/26/20 $323.13 +1.35% 5,91,765
19/26/19 $318.83 +0.28% 6,50,191
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Labcorp Holdings Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
18
Last Close Price
329.93USD
Average target price
345.12USD
Spread / Average Target
+4.61%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Labcorp Holdings Inc.